Tue 1 Dec 2009 | 3:11 EST

You are here: Home > Business & Finance > Stocks > Officers and Directors

Do More With Reuters

Partner Services

Affiliate Network

Professional Products

Support (Customer Zone)

Financial Products

About Thomson Reuters

Officers and Directors For AVI BioPharma, Inc.

AVI BioPharma, Inc. (AVII.O) (Consolidated Issue listed on NASDAQ Global Market)

sector: Healthcare . industry: Biotechnology · View AVII on other exchanges

As of 30 Nov 2009

1.42USD

Price Change

-0.04

Percent Change

-2.74%

Analyst Recommendations

Independent Research | Broker Research

Name	Age	Since	Current Position
Iversen, Patrick	53	2008	Senior Vice President - Strategic Alliances
Kole, Ryszard	62	2008	Senior Vice President - Discovery Research and Development
Weller, Dwight	58	2006	Senior Vice President - Chemistry and Manufacturing
Medeiros, Paul	--	2009	Senior Vice President - Business Development, Chief Business Officer
Hudson, Leslie	62	2008	President, Chief Executive Officer, Director
Hodgman, John	54	2004	Independent Director
Forrest, K. Michael	65	2008	Independent Director
Price, Gil	53	2007	Independent Director
Goolsbee, William	55	2007	Independent Director
Henney, Christopher	68	2009	Independent Director
Behrens, M. Kathleen	56	2009	Independent Director
Shrewsbury, Stephen	52	2009	Chief Medical Officer, Senior Vice President - Preclinical, Clinical and Regulatory Affairs
Boyle, J. David	55	2008	Chief Financial Officer, Senior Vice President, Secretary
Casey, Michael	63	2008	Chairman of the Board

Find out more about AVII.O

Insider Trading

Reuters.com: Help and Contact Us | Advertise With Us | Mobile | Newsletters | RSS | Labs | Journalism Handbook | Archive | Site Index | Video Index

Thomson Reuters Corporate: Copyright | Disclaimer | Privacy | Professional Products | Professional Products Support | About Thomson Reuters | Careers

International Editions: Africa | Arabic | Argentina | Brazil | Canada | China | France | Germany | India | Italy | Japan | Latin America | Mexico | Russia | Spain | United Kingdom | United States

Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.

NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.